片语

Breast mucinous carcinoma乳腺黏液癌

breast t carcinoma乳腺癌

Early breast ductal carcinoma早期乳腺导管癌

breast cancer乳腺癌

breast ductal carcinoma in situ乳腺导管内原位癌

breast ductal carcinoma乳腺导管癌

occult breast carcinoma隐匿性乳腺癌

BRCA Breast invasive carcinoma乳腺浸润性导管癌

breast carcinoma cells乳腺癌细胞

英汉例句

• Purpose To explore the morphologic and immunophenotypic characteristics of intraductal proliferative lesion in resected specimen of breast carcinoma and the correlation with invasive carcinoma.

  目的探讨乳腺癌切除标本内导管内增生性病变的形态和免疫表型特点及其与浸润癌之间的关系。

• Objective: to investigate the relationship among ER, PR of breast carcinoma and histological type, karyon grading, stromal responsive fibrosis, and the age of the patient.

  目的：探讨乳腺癌er、PR与癌组织的组织学类型、核分极、纤维间质增生及患者年龄等因素的关系。

• More florid ductal epithelial hyperplasia of the breast is shown here. There is a slightly increased risk (1.5 to 2 times normal) for breast carcinoma when such changes are present.

  乳腺导管上皮呈旺炽性增生。患乳腺癌的风险轻微增加(为正常的1.5到2倍)。

• Objective: To study the relationship between the expression of pS2 protein, prostate specific antigen (PSA) and breast carcinoma with neuroendocrine (ne) cells differentiation.

  目的：探讨雌激素调节蛋白(p S2)、前列腺特异抗原(psa)的表达与乳腺癌神经内分泌细胞(NE细胞)分化的关系。

• BRMS1 is a tumor metastasis suppressor gene discovered in breast carcinoma cells in 2000.

  BRMS1是2000年在乳腺癌细胞中发现的癌转移抑制基因。

• To investigate the expression of estrogen-induced protein PS2 in infiltrating ductal breast carcinoma and the relationship with clinicopathological parameters.

  探讨雌激素调节蛋白(PS 2)在乳腺浸润性导管癌中的表达及其与临床病理因素间的关系。

• Methods The clinical data of 84 patients with breast carcinoma were analyzed retrospectively.

  方法对我院84例乳腺癌病人进行回顾性分析。

• Purpose To study the clinicopathological features of breast carcinoma with responsive granuloma.

  目的：研究伴反应性肉芽肿的乳腺癌的临床病理特点。

• OBJECTIVE: to observe the effect of dihydroartemisinin on the proliferation and apoptosis in human breast carcinoma cell line T47D in vitro and explore the mechanism.

  目的：研究二氢青蒿素对乳腺癌细胞系t 47d的增殖、凋亡作用的影响，初步探讨其抗癌作用的分子机制。

• Conclusion no difference was found between BPBC and single lateral breast carcinoma in treatment, prognosis of BPBC was determined by clinical stages.

  结论：BPBC的治疗原则与单侧乳腺癌相比无明显差别，临床分期是判断BPBC预后的主要依据。

• The expression of PS2 in infiltrating ductal breast carcinoma is positively correlated with ER and PR, and its expression is also related to the status of axillary lymph node and clinical stage.

  乳腺浸润性导管癌中PS2的表达与ER、PR呈正相关关系，并与腋淋巴结状况和临床分期有关。

• Objective: Blood supply of breast carcinoma was studied for arterial chemotherapeutics infusion.

  目的：通过对乳腺癌肿瘤血供的研究，为动脉灌注化疗奠定基础。

• Methods The expression of survivin was studied in 66 breast carcinoma samples and 22 breast adenoma samples by immunohistochemical technique.

  方法应用免疫组织化学方法检测66例乳腺癌及22例乳腺腺瘤中survivin的表达。

• RESULTS: Primary malignant tumors included breast carcinoma (5 cases), lung carcinoma (14 cases) and colon carcinoma (1 case).

  结果：原发肿瘤包括乳腺癌5例，肺癌14例，结肠癌1例。

• The 6 lectins in 42 cases of atypical hyperplasia of breast and 10 cases of breast carcinoma and 10 cases of normal breast were studied by lectin affinity histochemical method.

  应用6种凝集素对42例乳腺非典型增生及10例乳腺癌、10例正常乳腺进行了亲合组化研究。

• Objective To investigate potential proliferative effect of erythropoietin on the Marine breast carcinoma cells in the treatment on chemotherapy -related anemia.

  目的：探讨红细胞生成素在治疗化疗相关性贫血的过程中对小鼠乳腺癌细胞的增殖有无促进作用。

• Methods The expression of CD44 in breast carcinoma and were detected by S-P immunohistochemistry method.

  方法用免疫组化S-P法检测乳腺癌及人正常乳腺组织中CD44的表达。

• Objective to detect telomerase activity in breast carcinoma by silver-staining telomeric repeat amplification protocol (TRAP).

  目的探讨应用银染端粒重复扩增技术(TRAP)检测乳腺癌组织端粒酶活性。